| Zacks Company Profile for HTG Molecular Diagnostics, Inc. (HTGM : NSDQ) |
|
|
| |
| • Company Description |
| HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona.
Number of Employees: 88 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.68 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 201,666 shares |
| Shares Outstanding: 8.59 (millions) |
| Market Capitalization: $5.81 (millions) |
| Beta: 1.99 |
| 52 Week High: $6.98 |
| 52 Week Low: $0.55 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-40.68% |
-35.27% |
| 12 Week |
-68.25% |
-66.58% |
| Year To Date |
-87.52% |
-85.46% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
3430 E. GLOBAL LOOP
-
TUCSON,AZ 85706
USA |
ph: 877-289-2615
fax: 520-547-2837 |
None |
http://www.htgmolecular.com |
|
|
| |
| • General Corporate Information |
Officers
John L. Lubniewski - President; Chief Executive Officer and Director
Ann F. Hanham - Chairman
Shaun D. McMeans - Senior Vice President; Chief Financial Officer; Tr
Laura L. Godlewski - Senior Vice President of Finance and Administratio
Harry A. George - Director
|
|
Peer Information
HTG Molecular Diagnostics, Inc. (ABMD)
HTG Molecular Diagnostics, Inc. (DMDS)
HTG Molecular Diagnostics, Inc. (CPWY.)
HTG Molecular Diagnostics, Inc. (EQUR)
HTG Molecular Diagnostics, Inc. (ECIA)
HTG Molecular Diagnostics, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 40434H203
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
|
|
Share - Related Items
Shares Outstanding: 8.59
Most Recent Split Date: 11.00 (0.07:1)
Beta: 1.99
Market Capitalization: $5.81 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.49 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-2.40 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/11/22 |
|
|
|
| |
